Analytical Data
-
Gene name
ZNF627
- Application
-
Alternative Names
ZNF627Zinc finger Protein 627
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q7L945
-
Expression Region
1-461 aa
-
AA Sequence
MDSVAFEDVAVNFTLEEWALLDPSQKNLYRDVMRETFRNLASVGKQWEDQNIEDPFKIPRRNISHIPERLCESKEGGQGEETFSQIPDGILNKKTPGVKPCESSVCGEVGMGPSSLNRHIRDHTGREPNEYQEYGKKSYTRNQCGRALSYHRSFPVRERTHPGGKPYDCKECGETFISLVSIRRHMLTHRGGVPYKCKVCGKAFDYPSLFRIHERSHTGEKPYECKQCGKAFSCSSYIRIHERTHTGDKPYECKQCGKAFSCSKYIRIHERTHTGEKPYECKQCGKAFRCASSVRSHERTHTGEKLFECKECGKALTCLASVRRHMIKHTGNGPYKCKVCGKAFDFPSSFRIHERTHTGEKPYDCKQCGKAFSCSSSFRKHERIHTGEKPYKCTKCGKAFSRSSYFRIHERTHTGEKPYECKQCGKAFSRSTYFRVHEKIHTGEKPYENPNPNASVVPVLS
-
Molecular Weight
50.8 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ZNF627 is a member of the zinc finger protein family, characterized by its ability to bind DNA and regulate gene expression. Research has increasingly focused on ZNF627 due to its potential role in various biological processes, including development, cell differentiation, and response to stress. Preliminary studies have suggested that ZNF627 may be involved in the regulation of gene networks linked to cancer progression and stem cell maintenance, making it a significant target for therapeutic intervention. The recombinant expression of ZNF627 allows researchers to study its structural and functional properties in detail, facilitating the identification of its binding partners and elucidating its mechanism of action within cellular pathways. Understanding the precise role of ZNF627 in gene regulation could lead to novel insights into its contribution to diseases, including its potential as a biomarker for cancer and other disorders. The production of ZNF627 as a recombinant protein also opens avenues for high-throughput screening of small molecules that may modulate its activity, offering promising strategies for drug development aimed at targeting dysregulated gene expression. Overall, the exploration of ZNF627 through recombinant protein studies represents an important aspect of current research aimed at unraveling complex gene regulatory networks and their implications in health and disease.
